Literature DB >> 34077061

The Epidemiology of COVID-19: A Review.

Joseph A Balogun1,2.   

Abstract

COVID-19 is a new lethal disease with limited information on its transmissibility, the severity of its sequelae, its clinical manifestations, and epidemiology. This commentary analyzed the global epidemiology of COVID-19 among the vulnerable population. The analysis revealed that most pediatric COVID-19 cases are not severe, but related severe illness still occurs in children. All ages of children are susceptible to COVID-19, and no significant gender difference exists. COVID-19 infection during pregnancy produced fatal outcomes for mothers, but less risky for the baby. The hot spot clusters for COVID-19 are the prisons/jails, nursing/group homes, and long-term facilities where most of the vulnerable populations reside. Ethnic minority groups in the USA and UK are disproportionately exposed to COVID-19 infection and death than Caucasians. The difference may be because ethnic minorities are exposed to higher risks at work and the long-standing structural economic and health disparities in the two countries. There are now changes in guidelines on who is qualified to receive ventilators in dire situations in many countries around the world if the healthcare system is overwhelmed.

Entities:  

Keywords:  COVID-19; Epidemiology

Year:  2020        PMID: 34077061     DOI: 10.29063/ajrh2020/v24i2s.16

Source DB:  PubMed          Journal:  Afr J Reprod Health        ISSN: 1118-4841


  2 in total

1.  Age Differences in Preferred Methods of Obtaining and Understanding Health Related Information During the COVID-19 Pandemic in Australia.

Authors:  Nathan Williams; Terry Haines; Cylie Williams; Kelly-Ann Bowles; Keith D Hill
Journal:  Front Public Health       Date:  2022-07-13

2.  Case report and systematic review suggest that children may experience similar long-term effects to adults after clinical COVID-19.

Authors:  Jonas F Ludvigsson
Journal:  Acta Paediatr       Date:  2020-12-03       Impact factor: 4.056

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.